Actas Dermo-Sifiliográficas

Survival of Interleukin-17 and Interleukin-23 Inhibitors in Patients Previously Treated With a Tumor Necrosis Factor Inhibitor: Analysis of the Spanish Biobadaderm Registry

marzo 26, 2026

Interleukin 12/23 inhibitors (IL12/23i) and interleukin 17 and 23 inhibitors (IL17i and IL23i) represent the drug classes with the most favorable expectations for therapeutic response. However, the introduction of biosimilars has led many centers, for […]

Dermatoscopic Findings of Adverse Nail Effects in Cancer Patients: Observational Study of 140 Patients

marzo 26, 2026

Background Chemotherapy can cause multiple dermatological alterations, including nail changes that significantly impact patients’ quality of life. This study aims to characterize the nail alterations induced by chemotherapy and assess their diagnosis through dermatoscopy. Methodology […]

Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study

marzo 26, 2026

Background Bimekizumab is the first and only dual selective inhibitor of IL-17 A and IL-17 F that has been proven effective and safe in Phase 3 clinical trials and has been approved by the European […]